These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 6849223

  • 1. The effects of nifedipine, a calcium antagonist, on platelet function.
    Dale J, Landmark KH, Myhre E.
    Am Heart J; 1983 Jan; 105(1):103-5. PubMed ID: 6849223
    [Abstract] [Full Text] [Related]

  • 2. In vitro adrenaline and collagen-induced mobilization of platelet calcium and its inhibition by naftopidil, doxazosin and nifedipine.
    Alarayyed NA, Cooper MB, Prichard BN, Betteridge DJ, Smith CC.
    Br J Clin Pharmacol; 1997 Apr; 43(4):415-20. PubMed ID: 9146854
    [Abstract] [Full Text] [Related]

  • 3. Disparate effects of the calcium-channel blockers, nifedipine and verapamil, on alpha 2-adrenergic receptors and thromboxane A2-induced aggregation of human platelets.
    Johnson GJ, Leis LA, Francis GS.
    Circulation; 1986 Apr; 73(4):847-54. PubMed ID: 3004784
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of platelet aggregation by diltiazem. Comparison with verapamil and nifedipine and inhibitory potencies of diltiazem metabolites.
    Kiyomoto A, Sasaki Y, Odawara A, Morita T.
    Circ Res; 1983 Feb; 52(2 Pt 2):I115-9. PubMed ID: 6831645
    [Abstract] [Full Text] [Related]

  • 5. Pacing induced angina and platelet reactivity.
    Thaulow E, Dale J, Kjekshus J, Simonsen S, Hovig T, Solum NO.
    Scand J Clin Lab Invest; 1982 Dec; 42(8):607-11. PubMed ID: 7167726
    [Abstract] [Full Text] [Related]

  • 6. Compared effects of three dose-levels of ticlopidine on platelet function in normal subjects.
    David JL, Monfort F, Herion F, Raskinet R.
    Thromb Res; 1979 Jan; 14(1):35-49. PubMed ID: 425084
    [No Abstract] [Full Text] [Related]

  • 7. Effects of nifedipine on platelet function.
    Takahara K, Kuroiwa A, Matsushima T, Nakashima Y, Takasugi M.
    Am Heart J; 1985 Jan; 109(1):4-8. PubMed ID: 3155583
    [Abstract] [Full Text] [Related]

  • 8. Postoperative platelet function in patients on small subcutaneous doses of heparin.
    Economopoulos TC, Papayannis AG, Stathakis NE, Arapakis G, Gardikas C.
    Acta Haematol; 1977 Jan; 57(5):266-71. PubMed ID: 403731
    [Abstract] [Full Text] [Related]

  • 9. Effect of the calcium antagonistic agent nifedipine on platelet aggregation response to exercise in patients with angina pectoris.
    Hiroki T, Inoue T, Yoshida T, Arakawa K.
    Arzneimittelforschung; 1982 Jan; 32(12):1572-4. PubMed ID: 6891598
    [Abstract] [Full Text] [Related]

  • 10. A single (investigator)-blind randomised control trial comparing the effects of quinapril and nifedipine on platelet function in patients with mild to moderate hypertension.
    Islim IF, Bareford D, Beevers DG.
    Platelets; 2001 Aug; 12(5):274-8. PubMed ID: 11487379
    [Abstract] [Full Text] [Related]

  • 11. Influence of teniposide on platelet functions in vitro.
    Kubisz P, Seghier F, Dobrotorá M, Stasko J, Cronberg S.
    Thromb Res; 1995 Jan 15; 77(2):145-8. PubMed ID: 7740506
    [Abstract] [Full Text] [Related]

  • 12. Isradipine: a potent calcium blocker with beneficial effects on platelet function and vascular prostacyclin production.
    Weiss K, Fitscha P, O'Grady J, Sinzinger H.
    Thromb Res; 1989 May 15; 54(4):311-7. PubMed ID: 2527422
    [Abstract] [Full Text] [Related]

  • 13. Nifedipine reduces thromboxane A2 production by platelets without changing aggregation in hypertensive pregnancy.
    Manninen A.
    Pharmacol Toxicol; 1996 Jun 15; 78(6):387-91. PubMed ID: 8829198
    [Abstract] [Full Text] [Related]

  • 14. [Effects of 2A-1-1 on the aggregation and Ca2+ influx of platelets].
    Zeng FR, Yin SM, Xie SF, Nie DN, Ma LP, Feng JH, Xu LZ, Guan YY.
    Zhonghua Xue Ye Xue Za Zhi; 2004 Sep 15; 25(9):544-7. PubMed ID: 15569534
    [Abstract] [Full Text] [Related]

  • 15. Antiplatelet activity of semotiadil fumarate.
    Wolfram RM, Kritz H, Oguogho A, Sinzinger H.
    Thromb Res; 2002 May 15; 106(4-5):187-90. PubMed ID: 12297124
    [Abstract] [Full Text] [Related]

  • 16. [Inhibition of platelet aggregation and thromboxane formation by the calcium antagonist nisoldipine following a single oral dose of 10 mg. A double-blind study in healthy probands].
    Schrör K, Latta G, Darius H, Klaus W, Ziegler R.
    Klin Wochenschr; 1985 Jan 02; 63(1):16-9. PubMed ID: 3838352
    [Abstract] [Full Text] [Related]

  • 17. The in-vitro effect of tirofiban, glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets.
    Ciborowski M, Tomasiak M, Rusak T, Winnicka K, Dobrzycki S.
    Blood Coagul Fibrinolysis; 2008 Sep 02; 19(6):557-67. PubMed ID: 18685439
    [Abstract] [Full Text] [Related]

  • 18. [Effects of nifedipine on platelet function in normal subjects at rest and during exertion].
    Bonnet J, Hourdille P, Boisseau M, Broustet JP.
    Rev Esp Cardiol; 1982 Sep 02; 35(5 Suppl 2):II109-13. PubMed ID: 7170401
    [No Abstract] [Full Text] [Related]

  • 19. Inhibition of rabbit platelet phosphodiesterase activity and aggregation by calcium channel blockers.
    Moore JB, Fuller BL, Falotico R, Tolman EL.
    Thromb Res; 1985 Nov 01; 40(3):401-11. PubMed ID: 2417362
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.